Gooding WE - Search Results

1

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.

Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, Heron DE, Grandis JR, Argiris A. Bauman JE, et al. Among authors: gooding we. Cancer. 2018 Oct 1;124(19):3881-3889. doi: 10.1002/cncr.31651. Epub 2018 Oct 6. Cancer. 2018. PMID: 30291796 Free PMC article. Clinical Trial.

2

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

3

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.

Vlock DR, Johnson J, Myers E, Day R, Gooding WE, Whiteside T, Pelch K, Sigler B, Wagner R, Colao D, et al. Vlock DR, et al. Among authors: gooding we. Head Neck. 1991 Jan-Feb;13(1):15-21. doi: 10.1002/hed.2880130103. Head Neck. 1991. PMID: 1989925

4

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ. Rubin Grandis J, et al. Among authors: gooding we. J Natl Cancer Inst. 1998 Jun 3;90(11):824-32. doi: 10.1093/jnci/90.11.824. J Natl Cancer Inst. 1998. PMID: 9625170

5

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.

Ribeiro U Jr, Finkelstein SD, Safatle-Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC. Ribeiro U Jr, et al. Among authors: gooding we. Cancer. 1998 Jul 1;83(1):7-18. Cancer. 1998. PMID: 9655287

6

Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.

Posner MC, Gooding WE, Landreneau RJ, Rosenstein MM, Clarke MR, Peterson MS, Lembersky BC. Posner MC, et al. Among authors: gooding we. Cancer J Sci Am. 1998 Jul-Aug;4(4):237-46. Cancer J Sci Am. 1998. PMID: 9689982 Clinical Trial.

7

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

8

Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.

Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Saito T, et al. Clin Cancer Res. 1999 Jun;5(6):1263-73. Clin Cancer Res. 1999. PMID: 10389908

9

Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.

Zeng Q, Smith DC, Suscovich TJ, Gooding WE, Trump DL, Grandis JR. Zeng Q, et al. Among authors: gooding we. Clin Cancer Res. 2000 Jun;6(6):2245-51. Clin Cancer Res. 2000. PMID: 10873074 Clinical Trial.

10

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.

Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Grandis JR, et al. Among authors: gooding we. Clin Cancer Res. 2000 Jul;6(7):2794-802. Clin Cancer Res. 2000. PMID: 10914726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters